Outlook Therapeutics named Greg DiPasquale as Chief Commercial Officer to lead the U.S. commercialization of LYTENAVA, the first FDA-approved ophthalmic bevacizumab for wet AMD. DiPasquale brings over 30 years of experience in retina product launches and will oversee market access, sales, and marketing as the company prepares to launch LYTENAVA by the end of 2026. This appointment is key for Outlook's strategy to make LYTENAVA widely available to patients with wet age-related macular degeneration in the U.S.
Outlook Therapeutics' appointment of Greg DiPasquale as Chief Commercial Officer provides context for healthcare sector activity. For readers following the health sector, here is Pluang's market snapshot as of Oct 09, 2026 18:51 WIB: of 128 priced US health stocks, 71 rose and 49 fell. Notable movers include Heron Therapeutics Inc (HRTX) at USD 0.37 with a 3.29% gain and CVS Health Corp (CVS) at USD 85.19 down 2.97%.
Stellar Lumens (XLM) price hovered around $0.20 with one-hour buying support but showed flat momentum and declining futures open interest, indicating limited conviction among traders. Key technical levels include $0.21 as resistance and $0.19 as supp...
ZEROBASE has stopped its DAT and perpetual-contract projects and reduced staff as it shifts strategy to cut costs due to weaker altcoin liquidity. CEO Mirror Tang said the company is now focusing spending only on essential areas, reducing R&D investm...
Bitcoin's price recovered to about $82,800 after a sharp sell-off that triggered over $1 billion in liquidations. The cryptocurrency faces strong resistance between $84,170 and $84,400, key levels it must surpass to attempt a move toward $87,000. Sup...
In early October, long-term U.S. Treasury yields stayed elevated above 5%, with the 10-year yield around 5.3% and the 30-year yield near 5.65%. Bond-market volatility, measured by the ICE BofA MOVE Index, was high at about 113.6 points, indicating in...
Bitcoin fell more than 4% in the week ending Oct. 10 after rising sharply in prior weeks, driven by increased transfers from short-term holders to exchanges, signaling potential selling pressure. Despite these moves, long-term holders remain mostly i...
